Navigation Links
Nanopills release drugs directly from the inside of cells

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria. Even though these inclusion bodies traditionally have been an obstacle in the industrial production of soluble enzymes and biodrugs, they were recently recognised to have large amounts of functional proteins with direct values in industrial and biomedical applications.

The research team led by Antoni Villaverde from the Institute of Biotechnology and Biomedicine (IBB) at UAB worked in collaboration with the spanish Centro de Investigacin Biomdica en Red en Bioingeniera, Biomateriales y Nanomedicina (CIBER-BBN) to verify the value of these nanoparticles as natural "nanopills" with a strong capacity to penetrate cells and carry out biological activities. The nanopill concept represents a new and promising platform for drug administration and illustrates the yet to be explored power of microbial materials in medicine.

The researchers, in a multidisciplinary study at UAB led by Dr Esther Vzquez, packaged four proteins containing different therapeutic effects into experimental nanopills, the inclusion bodies of the bacteria Escherichia coli. They put the bacteria in contact with cell cultures of mammals under similar conditions to those found in real clinical pathologies, "sick" cells with low viability, and achieved to recover their activity.

Once the technology was licensed to Janus Developments, the tolerance of its administration in vivo was confirmed through experiments conducted by UAB researcher Ester Fernndez. The results and detailed description of the "nanopill" were published in the last issue of the journal Advanced Materials.

The multidisciplinary study included researchers from IBB, the UAB Departments of Genetics and Microbiology and of Cell Biology, Physiology and Immunology, the CIBER-BBN, the CIBER-EHD (Centro de Investigacin Biomdica en Red en el rea temtica de Enfermedades hepticas y Digestivas), the firm Janus Developments, the Leibniz University of Hannover and the Helmholtz Centre for Infection Research in Germany.

The use of inclusion bodies as therapeutic agents was patented by UAB and CIBER-BBN (patent code: WO2010131117A1), and licensed to the biotechnology firm Janus Developments, which currently invests in the development of the product.


Contact: Antoni Villaverde
Universitat Autonoma de Barcelona

Related biology news :

1. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
2. Great bustards to be released on Salisbury Plain
3. SNM releases new fact sheet on breast cancer and molecular imaging
4. Loggerhead release to provide vital information to scientific community
5. Global warming predicted to hasten carbon release from peat bogs
6. American Dietetic Association releases 2008 nutrition trends survey
7. UH Manoa researchers release results of statewide survey of snail, slug invasions in Hawaii
8. The International Society for Stem Cell Research releases new guidelines
9. New online report on massive jellyfish swarms released
10. Hypertension and cholesterol medications present in water released into the St. Lawrence River
11. Complete Genomics releases proof-of-concept data for its sequencing technology for the first time
Post Your Comments:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... Today the Allen Institute announced the opening ... South Lake Union neighborhood, the city,s biotechnology hub. ... Westlake Avenue North, the 270,000 square foot life sciences ... Science and the Allen Institute for Cell Science. ... the Allen Institute. "We started by building a map ...
(Date:12/1/2015)... MOUNTAIN VIEW, Calif. , Dec. 1, 2015 ... introduce the Transformational Health program. This program addresses ... this period of change. ... --> Logo - ... Understanding every aspect of healthcare, as well as ...
(Date:12/1/2015)... 2015 ... "2016 Europe Cell Surface Markers: Country ... Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, ... --> ) has announced the ... Surface Markers: Country Volume and Sales Forecasts, ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... solutions provider, announces that its best selling system laboratory animal colony management software ... Cloud today, without investing in on-site IT resources., , ...
Breaking Biology Technology: